NCT06525363View on ClinicalTrials.gov

Clinical Assessment of Chitosan Nanoparticles on Periodontal Problems Post Steroidal Inhalation in Asthmatic Patients: Phase I Trial

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

March 1, 2025

Conditions

Periodontal Diseases

Interventions

DRUG

Chitosan

chitosan nanoparticles 1%w/w will be formulated in form of spray for oral application twice daily

Trial Locations (1)

05673

Soad A. Mohamad, Minya

All Listed Sponsors

lead

Deraya University

OTHER

NCT06525363 - Clinical Assessment of Chitosan Nanoparticles on Periodontal Problems Post Steroidal Inhalation in Asthmatic Patients: Phase I Trial | Biotech Hunter | Biotech Hunter